<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5//EN" "ep-patent-document-v1-5.dtd">
<!-- This XML data has been generated under the supervision of the European Patent Office -->
<ep-patent-document id="EP13857618B8W1" file="EP13857618W1B8.xml" lang="en" country="EP" doc-number="2925340" kind="B8" correction-code="W1" date-publ="20190724" status="c" dtd-version="ep-patent-document-v1-5">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>BDM Ver 0.1.67 (18 Oct 2017) -  2999001/0</B007EP><B070EP>The file contains technical information submitted after the application was filed and not included in this specification</B070EP></eptags></B000><B100><B110>2925340</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20190724</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>13857618.6</B210><B220><date>20131120</date></B220><B240><B241><date>20150619</date></B241><B242><date>20180213</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>201261729018 P</B310><B320><date>20121121</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20190724</date><bnum>201930</bnum></B405><B430><date>20151007</date><bnum>201541</bnum></B430><B450><date>20190508</date><bnum>201919</bnum></B450><B452EP><date>20181127</date></B452EP><B480><date>20190724</date><bnum>201930</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  38/34        20060101AFI20181112BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  38/06        20060101ALI20181112BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>A61K  38/07        20060101ALI20181112BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>A61K   8/64        20060101ALI20181112BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>A61Q  17/04        20060101ALI20181112BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>A61Q  19/00        20060101ALI20181112BHEP        </text></classification-ipcr><classification-ipcr sequence="7"><text>C07K   5/097       20060101ALI20181112BHEP        </text></classification-ipcr><classification-ipcr sequence="8"><text>C07K   5/117       20060101ALI20181112BHEP        </text></classification-ipcr><classification-ipcr sequence="9"><text>A61Q  19/04        20060101ALI20181112BHEP        </text></classification-ipcr><classification-ipcr sequence="10"><text>A61Q  19/08        20060101ALI20181112BHEP        </text></classification-ipcr><classification-ipcr sequence="11"><text>A61K  38/00        20060101ALI20181112BHEP        </text></classification-ipcr><classification-ipcr sequence="12"><text>A61P  17/00        20060101ALI20181112BHEP        </text></classification-ipcr><classification-ipcr sequence="13"><text>A61P  35/00        20060101ALI20181112BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ENTHALTEND SELEKTIVE AGONISTEN DES MELANOCORTIN-1-REZEPTORS ZUR VERWENDUNG IN THERAPIEVERFAHREN</B542><B541>en</B541><B542>PHARMACEUTICAL COMPOSITIONS COMPRISING SELECTIVE AGONISTS OF MELANOCORTIN 1 RECEPTOR AND THEIR USE IN THERAPEUTIC METHODS</B542><B541>fr</B541><B542>COMPOSITIONS PHARMACEUTIQUES COMPRENANT DES AGONISTES SÉLECTIFS DU RÉCEPTEUR DE LA MÉLANOCORTINE 1, ET LEUR UTILISATION DANS UNE MÉTHODE THÉRAPEUTIQUE</B542></B540><B560><B561><text>WO-A1-2011/063366</text></B561><B561><text>US-A1- 2006 003 386</text></B561><B561><text>US-A1- 2010 216 655</text></B561><B562><text>HOLDER JERRY RYAN ET AL: "STRUCTURE-ACTIVITY RELATIONSHIPS OF THE MELANOCORTIN TETRAPEPTIDE AC-HIS-DPHE-ARG-TRP-NH2 AT THE MOUSE MELANOCORTIN RECEPTORS: PART 2 MODIFICATIONS AT THE PHE POSITION", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 45, no. 14, 1 July 2002 (2002-07-01), pages 3073-3081, XP009077300, ISSN: 0022-2623, DOI: 10.1021/JM010524P</text></B562><B562><text>YANG Y ET AL: "Novel binding motif of ACTH analogues at the melanocortin receptors", BIOCHEMISTRY 20091020 AMERICAN CHEMICAL SOCIETY USA, vol. 48, no. 41, 20 October 2009 (2009-10-20), pages 9775-9784, XP055270052, DOI: 10.1021/BI900634E</text></B562><B562><text>CHEN M ET AL: "Functional characterization of the modified melanocortin peptides responsible for ligand selectivity at the human melanocortin receptors", PEPTIDES, ELSEVIER, AMSTERDAM, NL, vol. 27, no. 11, 1 November 2006 (2006-11-01), pages 2836-2845, XP027957587, ISSN: 0196-9781 [retrieved on 2006-11-01]</text></B562><B562><text>KOIKOV L N ET AL: "Sub-Nanomolar hMC1R Agonists by End-Capping of the Melanocortin Tetrapeptide His-D-Phe-Arg-Trp-NH2", BIOORGANIC &amp; MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 13, 1 January 2003 (2003-01-01), pages 2647-2650, XP002342336, ISSN: 0960-894X, DOI: 10.1016/S0960-894X(03)00552-3</text></B562><B562><text>ABDEL-MALEK ZALFA A ET AL: "alpha-MSH tripeptide analogs activate the melanocortin 1 receptor and reduce UV-induced DNA damage in human melanocytes", PIGMENT CELL &amp; MELANOMA RESEARCH, vol. 22, no. 5, October 2009 (2009-10), pages 635-644, XP009189878,</text></B562><B562><text>RUWE A R ET AL: "Semi-rigid tripeptide agonists of melanocortin receptors", BIOORGANIC &amp; MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 19, no. 17, 1 September 2009 (2009-09-01), pages 5176-5181, XP026458585, ISSN: 0960-894X [retrieved on 2009-07-09]</text></B562><B562><text>KOIKOV ET AL.: 'Analogs of sub-nanomolar hMC1 R agonist LK-184 [Ph( CH 2) 3CO-His-D-Phe-Arg-Trp-NH2). An additional binding site within the human melanocortin receptor 1?' BIOORGANIC &amp; MEDICINAL CHEMISTRY LETTERS., [Online] vol. 14, 09 June 2004, pages 3997 - 4000, XP055213969 Retrieved from the Internet: &lt;URL:http://www.sciencedirect.com/ science /article/pii/S0960894X04006900&gt;</text></B562><B562><text>CATANIA, A.: 'Melanocortins: Multiple Actions and Therapeutic Potential' ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY vol. 681, 2010, XP055263088 ISBN: 978-1-4419-6353-6 Retrieved from the Internet: &lt;URL:http://f3.tiera.ru/llgenesis/575-579/5 76000/103eeea76e1380c962de22f451fb36c24.&gt;</text></B562><B562><text>SINGH ET AL.: 'Incorporation of a Bioactive Reverse-Turn Heterocycle into a Peptide Template Using Solid-Phase Synthesis To Probe Melanocortin Receptor Selectivity and Ligand Conformations by 2D 1 H NMR' J. MED. CHEM., [Online] vol. 54, 09 February 2011, pages 1379 - 1390, XP055213971 Retrieved from the Internet: &lt;URL:http://pubs.acs.org/doi/abs/10.1021/jm 101425m.&gt;</text></B562><B565EP><date>20161207</date></B565EP></B560></B500><B700><B720><B721><snm>ABDEL-MALEK, Zalfa, A.</snm><adr><str>3307 Glenhurst Place</str><city>Cincinnati, OH 45209</city><ctry>US</ctry></adr></B721><B721><snm>KOIKOV, Leonid</snm><adr><str>4577 AnthonyStreet</str><city>Cincinnati, OH 45233</city><ctry>US</ctry></adr></B721><B721><snm>KNITTEL, James, J.</snm><adr><str>159 Barton Avenue</str><city>Belchertown, MA 01007</city><ctry>US</ctry></adr></B721></B720><B730><B731><snm>University Of Cincinnati</snm><iid>101142724</iid><irf>P37169EP/MRM</irf><adr><str>51 Goodman Drive 
Suite 240</str><city>Cincinnati, OH 45221-0829</city><ctry>US</ctry></adr></B731></B730><B740><B741><snm>Moore, Michael Richard</snm><sfx>et al</sfx><iid>101084582</iid><adr><str>Keltie LLP 
No.1 London Bridge</str><city>London SE1 9BA</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>US2013071033</anum></dnum><date>20131120</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2014081846</pnum></dnum><date>20140530</date><bnum>201422</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
